Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.

Chronic HBV infects 350 million people causing cancer and liver failure. We aimed to assess the safety and efficacy of plasmid DNA (pSG2.HBs) vaccine, followed by recombinant modified vaccinia virus Ankara (MVA.HBs), encoding the surface antigen of HBV as therapy for chronic HBV. A secondary goal wa...

Full description

Bibliographic Details
Main Authors:	James S Cavenaugh, Dorka Awi, Maimuna Mendy, Adrian V S Hill, Hilton Whittle, Samuel J McConkey
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2011-02-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3039644?pdf=render

Similar Items

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
by: Cavenaugh, J, et al.
Published: (2011)

Safety, immunogenicity, and efficacy results of a phase II trial of therapeutic vaccines for chronic HBV in the Gambia.
by: McConkey, S, et al.
Published: (2004)

Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
by: Crozier Sarah, et al.
Published: (2008-04-01)

Novel oligonucleotide assay detects HBV pre-core and basal core mutations in HBV-infected Gambians
by: Mendy, M, et al.
Published: (2006)

Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
by: Marianne A B van der Sande, et al.
Published: (2007-08-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
by: McConkey, S, et al.
Published: (2003)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
by: Louis-Marie Yindom, et al.
Published: (2017-01-01)

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis.
by: Gilbert, S, et al.
Published: (2006)

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.
by: Kelli K Ryckman, et al.
Published: (2010-08-01)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to HBV Infection: Haplotype Analysis.
by: Kelli K. Ryckman, et al.
Published: (2011-01-01)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
by: Yindom, L, et al.
Published: (2017)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
by: Mendy, M, et al.
Published: (2010)

A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.
by: Eoghan de Barra, et al.
Published: (2014-01-01)

A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS
by: De Barra, E, et al.
Published: (2014)

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.
by: Stewart, B, et al.
Published: (2011)

Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.
by: Mendy, M, et al.
Published: (2008)

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis
by: Ryckman, K, et al.
Published: (2010)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
by: Mokaya, J, et al.
Published: (2018)

Virological profiles of hepatitis B virus (HBV)-infected African patients treated with tenofovir
by: H.F. Njai, et al.
Published: (2014-04-01)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Branwen J Hennig, et al.
Published: (2008-03-01)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians
by: Hall Andrew, et al.
Published: (2010-09-01)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
by: Yael Gozlan, et al.
Published: (2022-03-01)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus Infection.
by: Branwen J. Hennig, et al.
Published: (2011-01-01)

Nurturing the Positive Mental Health of Autistic Children, Adolescents and Adults alongside That of Their Family Care-Givers: A Review of Reviews
by: Roy McConkey
Published: (2023-11-01)

A Brief Measure of Parental Wellbeing for Use in Evaluations of Family-Centred Interventions for Children with Developmental Disabilities
by: Roy McConkey
Published: (2020-09-01)

Responding to Autism in Low and Middle Income Countries (Lmic): What to Do and What Not to Do
by: Roy McConkey
Published: (2022-10-01)

Supporting Families through Early Intervention
by: Roy McConkey
Published: (2003-09-01)

IRRODL is Growing!
by: Brigette McConkey
Published: (2009-02-01)

Validation of hepatitis B surface antigen (HBsAg) rapid test to screen HBV infection in rural Gambia
by: H.F. Njai, et al.
Published: (2014-04-01)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
by: Young-Suk Lim
Published: (2023-01-01)

A hepatitis B virus-derived peptide combined with HBsAg exerts an anti-HBV effect in an HBV transgenic mouse model as a therapeutic vaccine
by: Yu-Min Choi, et al.
Published: (2023-06-01)

Lamivudine treatment for severe acute HBV hepatitis
by: Andrea Lisotti, Francesco Azzaroli, Federica Buonfiglioli, Marco Montagnani, Flavio Alessandrelli, Giuseppe Mazzella
Published: (2008-01-01)

mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model
by: Dorien De Pooter, et al.
Published: (2024-02-01)

Prevalence of HBV genotypes in South American immigrants affected by HBV-related chronic active hepatitis
by: Emilio Palumbo, et al.

In situ analysis of hepatitis B virus (HBV) antigen and DNA in HBV-induced hepatocellular carcinoma
by: Ye Zheng, et al.
Published: (2022-01-01)

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
by: Peto, T, et al.
Published: (2014)

Therapeutic vaccines in HBV: lessons from HCV
by: Barnes, E
Published: (2015)

Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses
by: Rollier, C, et al.
Published: (2016)

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults.
by: Moorthy, V, et al.
Published: (2004)

Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
by: Mariantonietta Di Stefano, et al.
Published: (2023-02-01)